Company Overview
Gynocare Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Monday 26 June 2000, so this is a well established company. Gynocare Limited has been in business for 25 years and 9 months. The accounts status is small and the accounts are next due on Wednesday 30 September 2026.
Registered Address

C/O Abbott Uk Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameGYNOCARE LIMITED
Company Number04021383
Registered Office AddressC/O Abbott Uk Abbott House
 Vanwall Business Park, Vanwall Road
 SL6 4XE
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date26/06/2000
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2026
Accounts Last Made Up Date31/12/2024
Accounts Account CategorySMALL
Returns Next Due Date24/07/2017
Returns Last Made Up Date26/06/2016
Previous Company NameChanged Date
MILLFORD MANAGEMENT LIMITED02 Jan 2007
Directors & Members
Show Resigned
Giulio Amore - Director
(Italian, 56 years old, born March 1970)
Appointed 01 June 2022
 Active
Ross Campbell - Director
(British, 50 years old, born April 1976)
Appointed 25 April 2025
 Active
Michael Clayton - Director
(British, 52 years old, born April 1974)
Appointed 23 March 2020
 Active
Julio Espinoza Ovalle - Director
(Chilean, 58 years old, born June 1968)
Appointed 01 April 2019
 Active
Secretaries
Show Resigned
Kevan Gogay - Secretary
(British)
Appointed 26 September 2014
 Active
Other Company Directorships
Giulio Amore
ABBOTT UK INVESTMENTS LIMITED
Ross Campbell
ABBOTT (UK) FINANCE LIMITED
ABBOTT (UK) HOLDINGS LIMITED
ABBOTT ASIA HOLDINGS LIMITED
ABBOTT ASIA INVESTMENTS LIMITED
ABBOTT AUSTRALASIA HOLDINGS LIMITED
ABBOTT CAPITAL INDIA LIMITED
ABBOTT EQUITY HOLDINGS UNLIMITED
ABBOTT HEALTHCARE PRODUCTS LTD
ABBOTT LABORATORIES LIMITED
ABBOTT UK INVESTMENTS LIMITED
ABBOTT UK SUBSIDIARY 2 LIMITED
ABBOTT UK SUBSIDIARY LIMITED
ABBOTT VASCULAR DEVICES (2) LIMITED
ABBOTT VASCULAR DEVICES LIMITED
BRITISH COLLOIDS LIMITED
KNOLL UK INVESTMENTS UNLIMITED
MUREX BIOTECH LIMITED
Michael Clayton
ABBOTT (UK) FINANCE LIMITED
ABBOTT (UK) HOLDINGS LIMITED
ABBOTT ASIA HOLDINGS LIMITED
ABBOTT ASIA INVESTMENTS LIMITED
ABBOTT AUSTRALASIA HOLDINGS LIMITED
ABBOTT CAPITAL INDIA LIMITED
ABBOTT EQUITY HOLDINGS UNLIMITED
ABBOTT HEALTHCARE CONNECTIONS LIMITED
ABBOTT HEALTHCARE PRODUCTS LTD
ABBOTT LABORATORIES LIMITED
ABBOTT UK INVESTMENTS LIMITED
ABBOTT UK SUBSIDIARY 2 LIMITED
ABBOTT UK SUBSIDIARY LIMITED
ABBOTT VASCULAR DEVICES (2) LIMITED
ABBOTT VASCULAR DEVICES LIMITED
BRITISH COLLOIDS LIMITED
FOURNIER PHARMACEUTICALS LIMITED
KNOLL UK INVESTMENTS UNLIMITED
LINGO TECHNOLOGY UK LIMITED
MANSBRIDGE PHARMACEUTICALS LIMITED
MUREX BIOTECH LIMITED
Julio Espinoza Ovalle
No companies found
Balance Sheet Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2019 31-Dec-2018
Balance Sheet
Fixed Assets 0 0 0
Current Assets 140,195 140,195 138,206
Creditors Due Within One Year 16,341 16,341 2,500
Working Cap 123,854 123,854 135,706
Total Assets Less Current Liabilities 123,854 123,854 135,706
Long-term Liabilities 0 0 0
Net Assets 123,854 123,854 135,706
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 123,854 123,854 135,706
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2019 31-Dec-2018
Tangible Fixed Assets - - -
Fixed Assets 0.0% 0.0% 0.0%
Stocks Inventory - - -
Debtors - - 1.8%
Cash Bank In Hand 100.0% 100.0% 98.2%
Current Assets 100.0% 100.0% 100.0%
Creditors Due Within One Year 11.7% 11.7% 1.8%
Net Current Assets Liabilities 88.3% 88.3% 98.2%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds 88.3% 88.3% 98.2%
Capital Employed - - -
Total Assets Less Current Liabilities 88.3% 88.3% 98.2%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2019 31-Dec-2018
Liquidity Ratio 8.6 8.6 55.3
Solvency Ratio 8.6 8.6 55.3
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2019 31-Dec-2018
Assets 140,195 140,195 138,206
Debt 16,341 16,341 2,500
Net Assets/Debt 123,854 123,854 135,706

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around SL6 4XE
ABBOTT LABORATORIES TRUSTEE COMPANY LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
ABBOTT LABORATORIES LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
BRITISH COLLOIDS LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
ABBOTT (UK) FINANCE LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
MUREX BIOTECH LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
MANSBRIDGE PHARMACEUTICALS LIMITED
Abbott House Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE
ABBOTT VASCULAR DEVICES LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
ABBOTT ASIA INVESTMENTS LIMITED
ABBOTT HOUSE VANWALL BUSINESS PARK, VANWALL ROAD, MAIDENHEAD, BERKSHIRE, SL6 4XE
ABBOTT IBERIAN INVESTMENTS LIMITED
Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE
ABBOTT IBERIAN INVESTMENTS (2) LIMITED
Abbott House Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE
Document Filings
Director's details changed for Mr Julio Espinoza on 5 December 2025
Confirmation statement made on 5 December 2025 with no updates
Appointment of Mr Ross Iain Campbell as a director on 25 April 2025
Termination of appointment of Neil Harris as a director on 25 April 2025
Confirmation statement made on 5 December 2024 with no updates
Confirmation statement made on 5 December 2023 with no updates
Confirmation statement made on 5 December 2022 with no updates
Auditor's resignation
Appointment of Giulio Amore as a director on 1 June 2022
Termination of appointment of Daniel John Hallett as a director on 31 May 2022
Confirmation statement made on 5 December 2021 with no updates
Register inspection address has been changed from Sovereign House Bingham Road Sittingbourne ME10 3SU England to Citco London Ltd 7 Albemarle Street London W1S 4HQ
Change of details for Abbott Laboratories Ltd as a person with significant control on 10 February 2021
Notification of Abbott Laboratories Ltd as a person with significant control on 6 April 2016
Withdrawal of a person with significant control statement on 8 February 2021
Confirmation statement made on 5 December 2020 with no updates
Appointment of Mr Michael Robert Kendall Clayton as a director on 23 March 2020
Termination of appointment of Georgios Mountrichas as a director on 23 March 2020
Confirmation statement made on 5 December 2019 with no updates
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free